4//SEC Filing
Brenner Malcolm 4
Accession 0001209191-21-017524
CIK 0001754068other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:34 PM ET
Size
20.8 KB
Accession
0001209191-21-017524
Insider Transaction Report
Form 4
Allovir, Inc.ALVR
Brenner Malcolm
Director
Transactions
- Sale
Common Stock
2021-03-02$37.35/sh−3,727$139,199→ 943,198 total(indirect: See Footnote) - Sale
Common Stock
2021-03-02$38.27/sh−7,317$280,016→ 935,881 total(indirect: See Footnote) - Sale
Common Stock
2021-03-03$36.91/sh−3,383$124,861→ 930,884 total(indirect: See Footnote) - Sale
Common Stock
2021-03-01$38.39/sh−12,825$492,327→ 955,794 total(indirect: See Footnote) - Sale
Common Stock
2021-03-02$39.14/sh−1,614$63,173→ 934,267 total(indirect: See Footnote) - Sale
Common Stock
2021-03-01$39.00/sh−8,869$345,900→ 946,925 total(indirect: See Footnote) - Sale
Common Stock
2021-03-03$37.73/sh−6,032$227,617→ 924,852 total(indirect: See Footnote) - Sale
Common Stock
2021-03-03$38.53/sh−8,500$327,472→ 916,352 total(indirect: See Footnote)
Holdings
- 30,197
Common Stock
Footnotes (10)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.
- [F10]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.30 to $38.93. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.61 to $38.60. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]Shares held by Salt Free LP. The Reporting Person has a controlling interest in Salt Free LP and may be deemed to beneficially own these securities. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.61 to $39.585. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F5]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.845 to $37.84. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F6]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.87 to $38.81. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F7]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.89 to $39.27. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F8]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.29 to $37.285. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F9]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $37.29 to $38.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Documents
Issuer
Allovir, Inc.
CIK 0001754068
Entity typeother
Related Parties
1- filerCIK 0001818068
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:34 PM ET
- Size
- 20.8 KB